Published on Technology Networks by Chris Driver, Director of IRT Architecture at IQVIA, this article discusses the use of big data and Interactive Response Technology (IRT) in clinical trials, allowing for real-time interim analysis and more informed decisions about trial modifications. It highlights the role of regulatory authorities in defining parameters for the use of AI and ML in trials, and the potential of these to revolutionize trials, improve patient retention, and enhance the quality of life for trial participants.
Improve quality and sustainability while reducing cost and risk
Published on Pharmaceutical Outsourcing
By Maxime Schuchewytsch, Associate Director of Product Management, Cenduit IRT, an IQVIA Business
Save upwards of $20,000 a month through automated supply optimization
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
.svg){kind=icon}
